Heterogeneous Effects of Calorie Content and Nutritional Components Underlie Dietary Influence on Pancreatic Cancer Susceptibility.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
14 07 2020
Historique:
received: 18 11 2019
revised: 26 05 2020
accepted: 17 06 2020
entrez: 16 7 2020
pubmed: 16 7 2020
medline: 30 4 2021
Statut: ppublish

Résumé

Pancreatic cancer is a rare but fatal form of cancer, the fourth highest in absolute mortality. Known risk factors include obesity, diet, and type 2 diabetes; however, the low incidence rate and interconnection of these factors confound the isolation of individual effects. Here, we use epidemiological analysis of prospective human cohorts and parallel tracking of pancreatic cancer in mice to dissect the effects of obesity, diet, and diabetes on pancreatic cancer. Through longitudinal monitoring and multi-omics analysis in mice, we found distinct effects of protein, sugar, and fat dietary components, with dietary sugars increasing Mad2l1 expression and tumor proliferation. Using epidemiological approaches in humans, we find that dietary sugars give a MAD2L1 genotype-dependent increased susceptibility to pancreatic cancer. The translation of these results to a clinical setting could aid in the identification of the at-risk population for screening and potentially harness dietary modification as a therapeutic measure.

Identifiants

pubmed: 32668252
pii: S2211-1247(20)30861-5
doi: 10.1016/j.celrep.2020.107880
pmc: PMC7370178
pii:
doi:

Substances chimiques

Dietary Carbohydrates 0
Dietary Fats 0
Dietary Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

107880

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0427
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT205915/Z/17/Z
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/B/000C0428
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Sci Transl Med. 2016 Jun 1;8(341):341ra76
pubmed: 27252175
Am J Clin Nutr. 2016 Jan;103(1):218-30
pubmed: 26657045
Am J Clin Nutr. 2006 Nov;84(5):1171-6
pubmed: 17093171
Nat Commun. 2013;4:2245
pubmed: 23941916
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
N Engl J Med. 2010 Apr 29;362(17):1605-17
pubmed: 20427809
Cancer Cell. 2016 Dec 12;30(6):968-985
pubmed: 27866851
J Virol. 1997 Nov;71(11):8157-66
pubmed: 9343166
J Oral Pathol Med. 2010 Apr;39(4):349-55
pubmed: 20040022
Nature. 2018 Aug;560(7719):499-503
pubmed: 30051890
Cell. 2017 Oct 19;171(3):642-654.e12
pubmed: 29053970
Pancreas. 2019 Jul;48(6):759-779
pubmed: 31206467
Nat Med. 2017 Feb;23(2):235-241
pubmed: 28024083
Nat Med. 2014 Oct;20(10):1193-1198
pubmed: 25261994
Cancer Res. 2011 Jul 1;71(13):4484-93
pubmed: 21673053
J Nutr. 1991 Jul;121(7):1129-34
pubmed: 2051233
Nat Biotechnol. 2012 Oct;30(10):918-20
pubmed: 23051804
Nature. 2018 Jun;558(7711):600-604
pubmed: 29925948
Biostatistics. 2011 Jan;12(1):1-17
pubmed: 20543033
Clin Endocrinol (Oxf). 2006 Feb;64(2):141-5
pubmed: 16430711
Nat Rev Cancer. 2002 Dec;2(12):897-909
pubmed: 12459728
Anal Chem. 2006 Feb 1;78(3):779-87
pubmed: 16448051
Annu Rev Cell Dev Biol. 2011;27:441-64
pubmed: 21985671
J Hum Genet. 2019 Jun;64(6):521-534
pubmed: 30858505
Nature. 2016 Aug 4;536(7614):41-47
pubmed: 27398621
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
PLoS One. 2015 Aug 19;10(8):e0136246
pubmed: 26287798
Science. 1987 Oct 9;238(4824):188-93
pubmed: 2821617
Nat Genet. 2010 Mar;42(3):224-8
pubmed: 20101243
Obes Surg. 2008 Sep;18(9):1183-7
pubmed: 18563497
Cancer Lett. 2007 Sep 8;254(2):298-307
pubmed: 17498870
PLoS Med. 2014 May 20;11(5):e1001647
pubmed: 24845081
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Cell. 1996 Feb 9;84(3):491-5
pubmed: 8608603
Mol Carcinog. 2012 Jan;51(1):119-27
pubmed: 22162236
Cancer Discov. 2016 Aug;6(8):852-69
pubmed: 27246539
Nat Genet. 2009 Sep;41(9):986-90
pubmed: 19648918
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Cancer Res. 2006 Sep 15;66(18):8927-30
pubmed: 16982728
Eur J Appl Physiol. 2010 Jun;109(3):397-404
pubmed: 20131064
J Am Coll Surg. 2004 May;198(5):722-31
pubmed: 15110805
Cell Metab. 2019 Sep 3;30(3):403-404
pubmed: 31378465
Int J Cancer. 2013 Feb 1;132(3):617-24
pubmed: 22610753
Gastroenterology. 2015 Oct;149(5):1252-1264.e4
pubmed: 26255042
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Ann Oncol. 2014 Oct;25(10):2065-2072
pubmed: 25057164
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Bioinformatics. 2017 Sep 1;33(17):2776-2778
pubmed: 28475694
Diabetes. 2017 May;66(5):1103-1110
pubmed: 28507210
Nature. 1994 Dec 1;372(6505):425-32
pubmed: 7984236
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
HPB (Oxford). 2008;10(5):371-6
pubmed: 18982154
Clin Gastroenterol Hepatol. 2008 Mar;6(3):275-82
pubmed: 18328435
BMC Bioinformatics. 2013 Jan 16;14:7
pubmed: 23323831
Nat Genet. 2016 Nov;48(11):1443-1448
pubmed: 27694958
Biomed Pharmacother. 2017 Aug;92:1038-1044
pubmed: 28609841
Cell. 2016 Jul 28;166(3):567-581
pubmed: 27374329
Pancreas. 2004 Oct;29(3):204-11
pubmed: 15367886
Ann Oncol. 2012 Apr;23(4):843-52
pubmed: 21890910
J Cell Sci. 2016 Apr 1;129(7):1287-92
pubmed: 26985062

Auteurs

James Dooley (J)

Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK; VIB Center for Brain and Disease Research, VIB, Leuven 3000, Belgium; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven 3000, Belgium.

Vasiliki Lagou (V)

VIB Center for Brain and Disease Research, VIB, Leuven 3000, Belgium; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven 3000, Belgium.

Jermaine Goveia (J)

Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven-University of Leuven, Leuven 3000, Belgium.

Anna Ulrich (A)

Department of Clinical & Experimental Medicine, University of Surrey, Guildford GU2 7XH, UK.

Katerina Rohlenova (K)

Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven-University of Leuven, Leuven 3000, Belgium.

Nathalie Heirman (N)

VIB Center for Brain and Disease Research, VIB, Leuven 3000, Belgium; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven 3000, Belgium.

Tobias Karakach (T)

Bioinformatics Core Laboratory, Children's Hospital Research Institute of Manitoba, Winnipeg, MB R3E 3P4, Canada; Rady Faculty of Health Sciences, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.

Yulia Lampi (Y)

VIB Center for Brain and Disease Research, VIB, Leuven 3000, Belgium; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven 3000, Belgium.

Shawez Khan (S)

Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven-University of Leuven, Leuven 3000, Belgium.

Jun Wang (J)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Science, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Tom Dresselaers (T)

Department of Imaging and Pathology, KU Leuven-University of Leuven, Leuven 3000, Belgium.

Uwe Himmelreich (U)

Department of Imaging and Pathology, KU Leuven-University of Leuven, Leuven 3000, Belgium.

Marc J Gunter (MJ)

Section of Nutrition and Metabolism, International Agency for Research on Cancer, World Health Organization, 69372 Lyon Cedex 08, France.

Inga Prokopenko (I)

Department of Clinical & Experimental Medicine, University of Surrey, Guildford GU2 7XH, UK; UMR 8199 - EGID, Institut Pasteur de Lille, CNRS, University of Lille, 59000 Lille, France; Section of Genetics and Genomics, Department of Metabolism, Digestion, and Reproduction, Imperial College London, London SW7 2AZ, UK. Electronic address: i.prokopenko@surrey.ac.uk.

Peter Carmeliet (P)

Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven 3000, Belgium; Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology and Leuven Cancer Institute (LKI), KU Leuven-University of Leuven, Leuven 3000, Belgium. Electronic address: peter.carmeliet@kuleuven.vib.be.

Adrian Liston (A)

Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK; VIB Center for Brain and Disease Research, VIB, Leuven 3000, Belgium; Department of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven 3000, Belgium. Electronic address: adrian.liston@babraham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH